Sodium-Glucose Cotransporter 2 Inhibitors and Amputations

被引:0
|
作者
Clements, Jennifer N. [1 ]
机构
[1] Presbyterian Coll Sch Pharm, Dept Pharm Practice, 307 N Broad St, Clinton, SC 29325 USA
关键词
D O I
10.1001/jamainternmed.2018.8134
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:451 / 452
页数:3
相关论文
共 50 条
  • [1] Sodium-Glucose Cotransporter 2 Inhibitors
    Erol, Cetin
    ANATOLIAN JOURNAL OF CARDIOLOGY, 2024, 28 (05): : 216 - 216
  • [2] Treatment with sodium-glucose cotransporter 2 inhibitors and risk of lower-limb amputations
    Tkac, Ivan
    Kozarova, Miriam
    Stancakova Yaluri, Alena
    Javorsky, Martin
    DIABETES OBESITY & METABOLISM, 2024, 26 (10): : 4803 - 4805
  • [3] Heart and Sodium-Glucose Cotransporter 2 Inhibitors: A Sodium Dilemma
    Oyesomi, Elizabeth T.
    Tabrizchi, Reza
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2022, 79 (05) : 641 - 643
  • [4] Sodium-glucose cotransporter inhibitors for diabetes
    Isaji, Masayuki
    CURRENT OPINION IN INVESTIGATIONAL DRUGS, 2007, 8 (04) : 285 - 292
  • [5] Sodium-Glucose Cotransporter 2 Inhibitors and Cardiac Remodeling
    Husam M. Salah
    Subodh Verma
    Carlos G. Santos-Gallego
    Ankeet S. Bhatt
    Muthiah Vaduganathan
    Muhammad Shahzeb Khan
    Renato D. Lopes
    Subhi J. Al’Aref
    Darren K. McGuire
    Marat Fudim
    Journal of Cardiovascular Translational Research, 2022, 15 : 944 - 956
  • [6] Sodium-glucose cotransporter 2 inhibitors and emphysematous cystitis
    Dubin, Ina
    Glick, Yair
    Schattner, Ami
    POSTGRADUATE MEDICAL JOURNAL, 2024, 100 (1190) : 946 - 947
  • [7] CARDIOPROTECTIVE MECHANISMS OF SODIUM-GLUCOSE COTRANSPORTER 2 INHIBITORS
    Mkrtumyan, Ashot M.
    Markova, Tatyana N.
    Mishchenko, Nadezhda K.
    DIABETES MELLITUS, 2021, 24 (03): : 291 - 299
  • [8] Benefits and Complications of Sodium-Glucose Cotransporter 2 Inhibitors
    Sangiovanni, Ryan J.
    DeVee, Carley E.
    US PHARMACIST, 2019, 44 (02) : HS9 - HS12
  • [9] Lipid effects of sodium-glucose cotransporter 2 inhibitors
    Lazarte, Julieta
    Kanagalingam, Tharsan
    Hegele, Robert A.
    CURRENT OPINION IN LIPIDOLOGY, 2021, 32 (03) : 183 - 190
  • [10] Sodium-glucose cotransporter 2 inhibitors and risk of nephrolithiasis
    Kristensen, Kasper B.
    Henriksen, Daniel P.
    Hallas, Jesper
    Pottegard, Anton
    Lund, Lars C.
    DIABETOLOGIA, 2021, 64 (07) : 1563 - 1571